DGAP-News: RNTS Media N.V.: Real-time bidding business

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 29, 2016 at 3:15 AM

DGAP-News: RNTS Media N.V.: Real-time bidding business accelerates RNTS Media's growth

DGAP-News: RNTS Media N.V. / Key word(s): Change in Forecast RNTS Media N.V.: Real-time bidding business accelerates RNTS Media's growth 29.07.2016 / 07:32 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- The Management Board of RNTS Media N.V. ("RNTS"), a leading mobile advertising technology company, increases the pro-forma revenue guidance from more than EUR160m to more than EUR185m for the full year 2016. The guidance upgrade is mainly based on above-plan growth of the real-time bidding (RTB) business of Fyber, in combination with improved outlook for Inneractive identified post-closing, similarly deriving from strong RTB business. Management expects to also translate the increased revenue into accelerated EBITDA improvement, while remaining negative on aggregate in 2016. For 2017, the company expects further strong revenue growth to more than EUR240m and EBITDA to reach break-even by the end of the calendar year, on a run-rate basis. The Group has invested strongly into the RTB technology over the last 14 months, initially with the acquisition of Falk Realtime in May 2015 and recently with the acquisition of Inneractive in July 2016. Falk Realtime, re-branded as Fyber RTB after full integration into the Fyber platform in H1 2016, enables programmatic trading and RTB for the existing ad exchange; and with Inneractive, RNTS Media added a leading mobile RTB exchange, which services more than 630m active users per month, to its monetization offering. In line with major market trends, both Fyber and Inneractive continue to invest into their programmatic trading capabilities, both with a focus on mobile video advertising. Already this year, more than two-thirds of all US digital display advertising is expected to be traded programmatically, showing 40% growth compared to last year. Mobile and especially mobile video are driving this growth, with mobile video programmatic spending outpacing desktop by 2017 (eMarketer). Andreas Bodczek, CEO of RNTS, said: "It is encouraging to see that our acquisition-driven growth strategy targeted towards programmatic trading and RTB was validated by strong market growth and a continuous shift in advertiser behaviour towards these buying technologies, and it further strengthens our already strong competitive position. We are confident that RNTS Media is ideally placed to capitalise on these market trends, given its comprehensive product suite. Our integrated offering of Mediation, Ad Exchange and Ad Serving enables app developers and publishers to connect to RTB demand across ad formats and regions." About RNTS Media RNTS Media is a leading mobile advertising technology company. Headquartered in Berlin, Germany and founded in 2010, it empowers app developers and publishers to generate business-critical revenue streams with targeted in-app advertising through its core assets Fyber, acquired in October 2014, and Inneractive, acquired in July 2016. RNTS Media is listed on the Prime Standard of Frankfurt Stock Exchange under symbol 'RNM.' For more information, visit www.rntsmedia.com. Investor Contact Sabrina Kassmannhuber ir@rntsmedia.com +49 30 609 855 555 Media Contact Natalia Sandin natalia.sandin@rntsmedia.com +1 650 201 8814 Bob Huxford Bob.Huxford@newgatecomms.com +44 20 7680 6550 --------------------------------------------------------------------------- 29.07.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: RNTS Media N.V. Johannisstr. 20 10117 Berlin Germany Phone: +49 30 609 855 528 E-mail: governance@rntsmedia.com Internet: www.rntsmedia.com ISIN: NL0010315453 WKN: A1J87D Listed: Regulated Market in Frankfurt (Prime Standard) End of News DGAP News Service --------------------------------------------------------------------------- 487467 29.07.2016

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...